Medicines, Poisons and Therapeutic Goods Regulation 2026
170Definitions
Start here
Get a plain-English read of 170
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
170 Definitions
170 Definitions
(1) In this part—
data source entity means—
(a) the Australian Health Practitioner Regulation Agency established under the Health Practitioner Regulation National Law, or
(b) a prescription exchange service prescribed by, or otherwise recognised for the purposes of, a law of the Commonwealth or another State or Territory, or
(c) an approved entity.
database means the database established under section 171.
monitored medicine means—
(a) a Schedule 8 substance, and
(b) a Schedule 4 substance specified in the following table—
| Benzodiazepine derivative that is a Schedule 4 substance | Bromazepam | Chlordiazepoxide | | Clobazam | Clonazepam | Clorazepate | | Codeine that is a Schedule 4 substance | Diazepam | Flurazepam | | Lorazepam | Medazepam | Midazolam | | Nitrazepam | Oxazepam | Prazepam | | Pregabalin | Quetiapine | Temazepam | | Tramadol | Triazolam | Zolazepam | | Zolpidem | Zopiclone | |
(2) In this part, a reference to an authorised practitioner does not include a veterinary practitioner.